• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Koo
  • Youtube
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

Tag: Zydus Cadila Vaccine

Centre Finalises Zydus Cadila Vaccine Price, Places Order For 1 Crore Jabs
Centre Finalises Zydus Cadila Vaccine Price, Places Order For 1 Crore Jabs

Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, the world's first plasmid DNA Vaccine, to the government of India at Rs 265 per dose...

Zydus Cadila Vaccine
Zydus Cadila Vaccine Rollout From Mid-Sept, Here Are Some Facts About ZyCoV-D

A day after getting the emergency use authorisation (EUA) in India, country's leading multinational pharmaceutical company Zydus Cadila has said that the commercial rollout of its ZyCoV-D vaccine will start from mid-September. The pharma major informed about the future rollout plan in a virtual press conference held on Saturday.

Zydus Cadila's ZyCoV-D Vaccine Gets Approval For Use In India
Zydus Cadila's ZyCoV-D Gets Emergency Authorisation For Use In India

The Drugs Controller General of India (DCGI) has granted authorization to Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D for emergency use in India.

dry run for covid vaccination
Corona Vaccine: Odisha needs 15mn doses to immunise vulnerable 50-plus age-group

Bhubaneswar: As the country’s Covid-19 vaccination plan received a boost with the emergency use nod given to two vaccines – Covishield and Covaxin – by the Subject Expert Committee of the Central Drugs Standard Controller Organsiation (CDSCO), the day also saw a massive mock drill in as many as 125 districts spread across all the […]

COVID-19: Zydus Cadila Vaccine Found Safe In Clinical Trials
COVID-19: Zydus Cadila Vaccine Found Safe In Clinical Trials

Ahmedabad: Zydus Cadila announced on Thursday that its plasmid DNA vaccine to prevent COVID-19 – ZyCoV-D – was found to be safe, well tolerated and immunogenic in the phase I and II clinical trials. The company is now planning to initiate phase III clinical trial in around 30,000 volunteers upon receiving necessary approvals. The phase […]

scrollToTop